Skip to main content
Medicine logoLink to Medicine
. 2019 Oct 25;98(43):e17868. doi: 10.1097/MD.0000000000017868

Effect of the angiotensin-receptor-neprilysin inhibitor in heart failure patients with left ventricular ejection fraction higher than 40%: Retraction

PMCID: PMC6824688  PMID: 31651909

The authors have requested a retraction of the article, “Effect of the angiotensin-receptor-neprilysin inhibitor in heart failure patients with left ventricular ejection fraction higher than 40%”[1] which appears in Volume 98, Issue 39 of Medicine. The authors have stated that there were mistakes in the methodology that make the conclusion of the article unreliable.

Footnotes

How to cite this article: Zhao M, Xin Y, Li J. Effect of the angiotensin-receptor-neprilysin inhibitor in heart failure patients with left ventricular ejection fraction higher than 40%. Medicine. 2019;98:43(e17868).

Reference

  • [1].Zhao M, Xin Y, Li J. Effect of the angiotensin-receptor-neprilysin inhibitor in heart failure patients with left ventricular ejection fraction higher than 40%. Medicine. 2019. 98:e17296. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES